T-2307
| Code | Size | Price |
|---|
| TAR-T40994-25mg | 25mg | £970.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC range, 0.0039 to 0.0625 μg/ml), and Aspergillus species (MIC range, 0.0156 to 4 μg/mL).
CAS:
873546-31-7
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
Eio Yamada, et al. ?T-2307 shows efficacy in a murine model of Candida glabrata infection despite in vitro trailing growth phenomena. Antimicrob Agents Chemother.?2010 Sep;54(9):3630-4.
Junichi Mitsuyama, et al. ?In vitro and in vivo antifungal activities of T-2307, a novel arylamidine. Antimicrob Agents Chemother.?2008 Apr;52(4):1318-24.